Skip to main content
Ian Sobel

Ian Sobel, Bcom

Chief Executive Officer, BioHarvest Sciences
Ilan Sobel has been the CEO of BioHarvest Sciences since July 2020. Bringing a commercial focus in Go-To-Market planning and execution, Ilan has scaled production capabilities from Research & Development levels up to industrial scale, and is building a biotech company with novel, and even patentable plant-based products that are based on science and backed by clinical trials. Ilan has added the office of Chief Medical Officer, which leads both Clinical Trials and Direct-to-Doctor initiatives. Ilan has worked in diverse global jurisdictions, and is based in Israel. Prior to BioHarvest, Ilan served for 6 years at  Weissbeerger, as both Chief Operating Officer and then Chief Commercial Officer. In this capacity, Ilan played a major leadership role in building a disruptive BIG Data, IOT & Software Company servicing major Beverage players which was ultimately purchased by Anheuser Busch InBev. Previously, Ilan served an 18 year stint as an International Employee of The Coca-Cola Company, where he played a pivotal role in key senior leadership positions generating significant revenue and profit growth and improving brand health trends across diverse global markets.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.